| CXH | NAD | CXH / NAD | |
| Gain YTD | 1.939 | 1.169 | 166% |
| Net Assets | 70.5M | 2.83B | 2% |
| Total Expense Ratio | 0.00 | 1.41 | - |
| Turnover | 21.00 | 21.00 | 100% |
| Yield | 4.44 | 4.18 | 106% |
| Fund Existence | 37 years | 27 years | - |
| CXH | NAD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 58% | N/A |
| Stochastic ODDS (%) | 2 days ago 61% | 2 days ago 67% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 81% | 2 days ago 61% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 75% | 2 days ago 77% |
| Advances ODDS (%) | 8 days ago 84% | 3 days ago 77% |
| Declines ODDS (%) | N/A | 14 days ago 72% |
| BollingerBands ODDS (%) | 2 days ago 64% | 2 days ago 60% |
| Aroon ODDS (%) | 2 days ago 66% | N/A |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VNVCX | 16.26 | 0.16 | +0.99% |
| Natixis Vaughan Nelson Mid Cap C | |||
| TCMVX | 17.96 | 0.14 | +0.79% |
| Nuveen Mid Cap Value A | |||
| RYWAX | 58.58 | -0.28 | -0.48% |
| Rydex S&P SmallCap 600 Pure Growth H | |||
| DRDAX | 24.88 | -0.19 | -0.76% |
| Dearborn Partners Rising Dividend A | |||
| JBGCX | 52.51 | -1.04 | -1.94% |
| JHancock Blue Chip Growth C | |||
A.I.dvisor tells us that NAD and NIQ have been poorly correlated (+-9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NAD and NIQ's prices will move in lockstep.